Pityriasis Rubra Pilaris, Refractory to IL-17A Inhibition, with Rapid Improvement Following IL-17A/IL-17F Blockade by Bimekizumab. SKIN The Journal of Cutaneous Medicine, [S. l.], v. 8, n. 6, p. 1987–1992, 2024. DOI: 10.25251/skin.8.6.13. Disponível em: https://skin.dermsquared.com/skin/article/view/2980. Acesso em: 2 may. 2026.